Undertreatment and Underachievement of LDL-C Target among Individuals with High and Very High Cardiovascular Risk in the Malaysian Community
Dyslipidaemia is a major cause of morbidity and mortality. The aims of this study are to determine the prevalence of dyslipidaemia subtypes, the proportions of lipid-lowering therapy (LLT) use, and the achievement of low-density lipoprotein cholesterol (LDL-C) treatment targets for high-risk (HR) an...
Main Authors: | Aimi Zafira Razman, Noorhida Baharudin, Noor Alicezah Mohd Kasim, Alyaa Al-Khateeb, Zaliha Ismail, Hapizah Nawawi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9032/10/12/2448 |
Similar Items
-
Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an Observational Study of Treatment Patterns and Lipid Control
by: Hrvoje Pintarić, et al.
Published: (2020-01-01) -
Recommendations on the post-acute management of the osteoporotic fracture - Patients with “very-high” Re-fracture risk
by: Ronald Man Yeung Wong, et al.
Published: (2022-11-01) -
IMPACT OF ENACTMENT OF THE NEW PENAL CODE ON THE OFFENCE OF INTERNATIONAL HIGH RISK DRUG TRAFFICKING
by: Traian DIMA, et al.
Published: (2015-07-01) -
Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States
by: Seth J. Baum, et al.
Published: (2021-06-01) -
Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS)
by: M. V. Yezhov, et al.
Published: (2019-06-01)